November 28, 2012 at 08:30 AM EST
Free Research Reports on FB, ACAD, INTC and MU Issued by Investors-Alliance

NEW YORK, NY -- (Marketwire) -- 11/28/12 -- Facebook Inc. (NASDAQ: FB) continues to see growth in Monthly active users (MAUs), recently surpassing 1.01 billion, an increase of 26% year-over-year. We see opportunity in the adoption of mobile, with Facebook's Mobile MAUs increasing at a rate of 61% year-over-year. This is in large part to Facebook's strategy of tight integration with iOS and Android, opening the gateway for mobile ad revenue which is expected to... (Continue Reading).

Access the Free Research Report on Facebook including analyst opinion, price targets and complete financial analysis at: www.Investors-Alliance.com/r/bloomberg/781f_FB

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) announced successful Phase III trial results for Pimavanserin. There is currently no FDA-approved therapy to treat PDP in the United States. 60 percent of patients with Parkinson's disease (1 Million Americans, 10 Million worldwide) develop PDP and with average medication costs at $2,500 per year (for Parkinson's patients), we estimate sales upside for Pimavanserin to be between... (Continue Reading).

Access the Free Research Report on ACADIA including analyst opinion, price targets and complete financial analysis at: www.Investors-Alliance.com/r/bloomberg/4b43_ACAD

Intel Corporation (NASDAQ: INTC) is the foremost processor manufacturer, delivering consistent quality and performance -- an important element its competitors fail to match. PC and Notebook Manufacturers looking to produce high-quality products, particularity HP (19% of Intel's income) and Dell (15%), are likely to remain big buyers of Intel's processors. Although there remains threat from ARM architecture and macroeconomic influences (accounting for Intel's recent downward guidance adjustment), Intel's current share price is... (Continue Reading).

Access the Free Research Report on Intel including analyst opinion, price targets and complete financial analysis at: www.Investors-Alliance.com/r/bloomberg/39b3_INTC

Micron Technology, Inc. (NASDAQ: MU) remains one of the largest producers of DRAM and with the upcoming combination of Micron and Elpida, it will have the strongest product portfolio in the industry. We believe this is a net positive, as the Elpida buyout positions Micron as a direct supplier of DRAM for Apple's iPhone and iPad product lines. Mobile devices typically have higher margins than PC DRAM and demand for mobile is growing at a much faster rate, providing a larger offset to Moore's law price declines. Overall, this shift in strategy should... (Continue Reading).

Access the Free Research Report on Micron including analyst opinion, price targets and complete financial analysis at: www.Investors-Alliance.com/r/bloomberg/91a9_MU

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here